Table 4 Comparison of patient characteristics, risk factors, and clinical data based on the elevation of inflammatory markers
Low WBC (< 12.0 × 103/μl), n = 12 | High WBC < 12.0 × 103/μl), n = 22 | p | Low CRP (< 10.0 mg/dL), n = 17 | High CRP (> 10.0 mg/dL), n = 17 | p | |
|---|---|---|---|---|---|---|
Age, years | 71.6 ± 5.9 | 77.9 ± 9.0 | 0.04 | 73.0 ± 6.6 | 78.4 ± 9.5 | 0.06 |
Male gender, n (%) | 10 (83) | 15 (68) | 0.44 | 13 (76) | 12 (71) | 1.00 |
HTN, n (%) | 10 (83) | 15 (68) | 0.44 | 14 (82) | 11 (65) | 0.44 |
DM, n (%) | 1 (8) | 4 (18) | 0.64 | 3 (18) | 2 (23) | 0.44 |
CAOD, n (%) | 1 (8) | 5 (23) | 0.40 | 4 (24) | 2 (23) | 0.66 |
CVA, n (%) | 4 (33) | 3 (14) | 0.21 | 5 (29) | 2 (23) | 0.40 |
CRF, n (%) | 1 (8) | 1 (5) | 1.00 | 2 (23) | 0 (0) | 0.49 |
Antiplatelet agent, n (%) | 6 (50) | 13 (59) | 0.61 | 12 (71) | 7 (41) | 0.08 |
Statin, n (%) | 6 (50) | 10 (45) | 0.80 | 10 (59) | 6 (35) | 0.17 |
Mural thrombus, ml | 51.4 ± 3.2 | 92.0 ± 7.4 | 0.03 | 53.6 ± 6.5 | 101.7 ± 7.9 | 0.03 |
Fresh thrombus, ml | 49.5 ± 4.4 | 39.1 ± 4.0 | 0.49 | 41.8 ± 3.9 | 43.8 ± 4.9 | 0.89 |
Gas formation, n (%) | 6 (50) | 11 (50) | 1.00 | 7 (41) | 10 (59) | 0.30 |
ICU stay, hours | 17.2 ± 9.0 | 25.3 ± 15.9 | 0.11 | 21.9 ± 15.8 | 23.0 ± 13.0 | 0.83 |
Hospital stay, days | 6.7 ± 4.5 | 11.6 ± 15.1 | 0.28 | 11.1 ± 17.1 | 8.6 ± 5.3 | 0.58 |